Results of the present study also suggest that EGF-induced CaM redistribution from the nucleus to the cytoplasm facilitates the activation of invadopodia-associated proteins, leading to invadopodia formation and GBM invasion (Fig. 9), and that CaM is a candidate therapeutic target for impeding GBM invasion. The gene discussed is EGF; the disease is glioblastoma.